Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ DcRoW
|'}r-}
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© {J)gS
o@$pyU8
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© w?fq%-6f*
ze8 MFz'm
1.Co-stimulators (or co-stimulating molecules) AKLFUk
c.-dwz
2.NK-kB KCa @0
%,8
"cM`D
3.Immunoglobulin superfamily Lrt~Q:z2u
(L1O;~$
4.antigen-presenting cell (APC) =td(}3|D
Y
? R[GSS1
5.death domain PEtr8J$uB
<pT1p4T<
6.CCR and CXCR SrWmV@"y
1TN+pmc}@
7.Lectin (or mitogen) oB!-JX9
l@<Jp *|
8.Clusters of differentiation, CD) FSZ :}Q
~^~+p
9.B7 family W\ARCcTQ
kQ6YQsJ.*
10.Cytotoxic T lymphocyte, CTL)
]>(pQD
,{RWs^W2
11.IL-15 and IL-15 receptor (IL-15R) RL"hAUs_1
,UT :wpc^i
12.MHC restriction gl
n
X C
C !Lu`y
13.Affinity-chromatography "?
5@j/
e`
=~$)Ieu
14.Cyctosprin A, CsA d^aLue>g;+
u9}LvQh_6,
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) C #@5
:$
/T<,vR
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© sGbk4g
Zdu8axK:
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 RjHKFB2
J35[GZ';D
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ IqjH
;u?H#\J,
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 4d
@
(>
Dj{t[z]$k
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© n0@ \x=9
HN
L;s5gq
ÃâÒßѧרҵ£º 8IihG
\
rt!Uix&
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ vM/D7YS:
I/w=!Ih
Ïû»¯ÄÚ¿Æ£º UYOR@x #
<nT).S>+
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 0%hOB:
vZ2/>}!Z=
ѪҺ²¡Ñ§×¨Òµ£º A^hFR
Ag4
w}QU;rl8q
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿